J B Chemicals AND Pharmaceuticals Limited — Bromhexine Exporter Profile
Indian Pharmaceutical Exporter · #4 for Bromhexine · $907.7K export value · DGFT Verified
J B Chemicals AND Pharmaceuticals Limited is the #4 Indian exporter of Bromhexine with $907.7K in export value and 48 verified shipments. J B Chemicals AND Pharmaceuticals Limited holds a 5.6% market share in Bromhexine exports across 3 countries. The company exports 20 pharmaceutical products worth $47.9M across 12 therapeutic categories.
J B Chemicals AND Pharmaceuticals Limited — Bromhexine Export Profile: Buyers & Destinations
Where Does J B Chemicals AND Pharmaceuticals Limited Export Bromhexine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| AUSTRALIA | $756.1K | 32 | 71.7% |
| SINGAPORE | $279.1K | 19 | 26.5% |
| HONG KONG | $19.3K | 2 | 1.8% |
J B Chemicals AND Pharmaceuticals Limited exports Bromhexine to 3 countries. The largest destination is AUSTRALIA accounting for 71.7% of J B Chemicals AND Pharmaceuticals Limited's Bromhexine shipments, followed by SINGAPORE (26.5%) and HONG KONG (1.8%). These destinations reflect J B Chemicals AND Pharmaceuticals Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Bromhexine from J B Chemicals AND Pharmaceuticals Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| INOVA PHARMACEUTICALS(AUSTRALIA) PT | AUSTRALIA | $380.4K | 17 |
| INOVA PHARMACEUTICALS(SINGAPORE) PT | SINGAPORE | $233.9K | 17 |
| INOVA PHARMACEUTICALS (AUSTRALIA) P | AUSTRALIA | $141.2K | 4 |
| INOVA PHARMACEUTICALS AUSTRALIA PT | AUSTRALIA | $70.5K | 2 |
| INOVA PHARMACEUTICALS AUSTRALIA P | AUSTRALIA | $67.5K | 2 |
| Y LIMITED 5 MILLNER AVENUE HORSLEY PARK | AUSTRALIA | $62.4K | 6 |
| INOVA PHARMACEUTICALS SINGAPORE PT | SINGAPORE | $45.3K | 2 |
| INOVA PHARMACEUTICALS AUSTRALIA PT Y LTD | AUSTRALIA | $34.1K | 1 |
| ZUELLIG PHARMA LIMITED (HK) | HONG KONG | $19.3K | 2 |
J B Chemicals AND Pharmaceuticals Limited supplies Bromhexine to 9 buyers globally. The largest buyer is INOVA PHARMACEUTICALS(AUSTRALIA) PT (AUSTRALIA), followed by INOVA PHARMACEUTICALS(SINGAPORE) PT (SINGAPORE) and INOVA PHARMACEUTICALS (AUSTRALIA) P (AUSTRALIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Bromhexine Export Value and How Much Does J B Chemicals AND Pharmaceuticals Limited Contribute?
India exported $10.3M worth of Bromhexine through 1,945 shipments from 288 suppliers to 109 countries, serving 530 buyers globally. J B Chemicals AND Pharmaceuticals Limited contributes $907.7K to this total, accounting for 5.6% of India's Bromhexine exports. J B Chemicals AND Pharmaceuticals Limited ships Bromhexine to 3 countries through 9 buyers.
What Is the Average Shipment Value for J B Chemicals AND Pharmaceuticals Limited's Bromhexine Exports?
J B Chemicals AND Pharmaceuticals Limited's average Bromhexine shipment value is $18.9K per consignment, based on 48 shipments totaling $907.7K. The largest destination is AUSTRALIA (71.7% of J B Chemicals AND Pharmaceuticals Limited's Bromhexine exports).
How Does J B Chemicals AND Pharmaceuticals Limited Compare to Other Indian Bromhexine Exporters?
J B Chemicals AND Pharmaceuticals Limited ranks #4 among 288 Indian Bromhexine exporters with a 5.6% market share. The top 3 exporters are UMAVIDA PHARMA PRIVATE LIMITED ($2.6M), EMCURE PHARMACEUTICALS LIMITED ($2.1M), J B CHEMICALS AND PHARMACEUTICALS LIMITED ($907.7K). J B Chemicals AND Pharmaceuticals Limited processed 48 shipments to 3 destination countries.
What Bromhexine Formulations Does J B Chemicals AND Pharmaceuticals Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| CETYLPYRIDINIUM CHLORIDE AND BROMHEXINE | $543.8K | 18 |
| CETYLPYRIDINIUM CHLORIDE AND BROMHEXINEHYDROCHLORIDE ANTISEPTIC LOZENGES SUGARFREE LEMON FLAVOURS EACH LOZENGE | $92.8K | 3 |
| CETYLPYRIDINIUM CHLORIDE AND BROMHEXINEHYDROCHLORIDE ANTISEPTIC LOZENGES SUGARFREE LEM FLAVOURS EACH LOZENGE CONTAINS | $88.7K | 5 |
| CETYLPYRIDINIUM CHLORIDE AND BROMHEXINEHYDROCHLORIDE ANTISEPTIC LOZENGES SUGARFREE LEMON FLAVOURS EACH LOZENGENOS | $62.4K | 6 |
| CETYLPYRIDINIUM CHLORIDE AND BROMHEXINEHYDROCHLORIDE ANTISEPTIC LOZENGES SUGARFREE LEM FLAVOURS EACH LOZENGE CONTAINS | $44.1K | 1 |
| CETYLPYRIDINIUM CHLORIDE AND BROMHEXINEHYDROCHLORIDE ANTISEPTIC LOZENGES SUGARFREE LEM FLAVOURS EACH LOZENGE CONTAINSNOS | $39.3K | 6 |
| CETYLPYRIDINIUM CHLORIDE AND BROMHEXINEHYDROCHLORIDE ANTISEPTIC LOZENGES SUGARFREE LEMON FLAVOURS | $37.1K | 1 |
| CETYLPYRIDINIUM CHLORIDE AND BROMHEXINEHYDROCHLORIDE ANTISEPTIC LOZENGES SUGARFREE LEMON FLAVOURS.EACH LOZENGE CONTAINS | $34.6K | 3 |
| CETYLPYRIDINIUM CHLORIDE AND BROMHEXINEHYDROCHLORIDE ANTISEPTIC LOZENGES SUGARFREE BERRY FLAVOURS.EACH LOZENGENOS | $34.4K | 3 |
| CETYLPYRIDINIUM CHLORIDE AND BROMHEXINEHYDROCHLORIDE ANTISEPTIC LOZENGES SUGARFREE BERRY FLAVOURS EACH LOZENGE | $33.6K | 1 |
J B Chemicals AND Pharmaceuticals Limited exports 12 distinct Bromhexine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CETYLPYRIDINIUM CHLORIDE AND BROMHEXINE with 18 shipments worth $543.8K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Bromhexine to Key Markets
What J B Chemicals AND Pharmaceuticals Limited must comply with to export Bromhexine to its top destination countries
Australia — TGA
Approval Process
Registration on Australian Register of Therapeutic Goods (ARTG). Bioequivalence and quality data per TGA guidelines.
Timeline: 10–14 months
GMP & Export Requirements
TGA GMP clearance; PIC/S-aligned inspection. PIC/S certificate from India may expedite.
TGA sponsor licence for Australian importer; GMP clearance per manufacturing site
Note: TGA participates in PIC/S mutual recognition.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does J B Chemicals AND Pharmaceuticals Limited Compare to Nearest Bromhexine Exporters?
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | UMAVIDA PHARMA PRIVATE LIMITED | $2.6M | 53 | 1 | $49.4K |
| 2 | EMCURE PHARMACEUTICALS LIMITED | $2.1M | 119 | 14 | $18.0K |
| 4 | J B CHEMICALS AND PHARMACEUTICALS LIMITED ★ | $907.7K | 48 | 3 | $18.9K |
| 5 | AGIO PHARMACEUTICALS LIMITED | $849.1K | 41 | 4 | $20.7K |
| 6 | LINCOLN PHARMACEUTICALS LTD | $600.0K | 12 | 5 | $50.0K |
J B Chemicals AND Pharmaceuticals Limited ranks #4 among 288 Indian Bromhexine exporters. Average shipment value of $18.9K compared to the market average of $35.7K. The closest competitors by value are UMAVIDA PHARMA PRIVATE LIMITED and EMCURE PHARMACEUTICALS LIMITED.
Which Indian Ports Ship Bromhexine Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 303 | 15.6% |
| JNPT | 169 | 8.7% |
| JNPT/ NHAVA SHEVA SEA | 164 | 8.4% |
| SAHAR AIR CARGO ACC (INBOM4) | 157 | 8.1% |
| AHEMDABAD ICD | 74 | 3.8% |
| SAHAR AIR | 73 | 3.8% |
| AHEMDABAD AIR ACC (INAMD4) | 72 | 3.7% |
| AHEMDABAD ICD (INSBI6) | 59 | 3.0% |
What Other Respiratory & OTC Products Does J B Chemicals AND Pharmaceuticals Limited Export?
J B Chemicals AND Pharmaceuticals Limited also exports these respiratory & otc products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on J B Chemicals AND Pharmaceuticals Limited's Bromhexine Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like JB Pharma. The Israel-Iran tensions have led to increased security risks in the Red Sea, prompting major shipping lines to implement 'Emergency Risk Surcharges' ranging from $250 to $500 per TEU. This escalation in shipping costs directly impacts the profitability of exports to Europe and the US East Coast, necessitating strategic adjustments in pricing and logistics.
Conversely, the US-China trade tensions have opened avenues for Indian pharmaceutical companies to capture market share previously held by Chinese manufacturers. JB Pharma can leverage this shift by emphasizing its compliance with stringent US regulatory standards and its capacity to meet large-scale demands.
The recent India–European Union Free Trade Agreement, concluded in January 2026, eliminates tariffs on Indian pharmaceuticals entering the EU market. This development offers JB Pharma a competitive advantage, potentially increasing its export volumes to Europe and enhancing its market presence.
J B Chemicals AND Pharmaceuticals Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. JB Pharma's adherence to FDA, WHO, and EU Good Manufacturing Practices (GMP) ensures the quality and safety of its products, facilitating access to regulated markets. The evolving regulatory environment, including the EU's Falsified Medicines Directive, requires continuous investment in serialization and traceability systems. JB Pharma's proactive approach to these requirements underscores its commitment to quality and patient safety.
About J B Chemicals AND Pharmaceuticals Limited
J B Chemicals AND Pharmaceuticals Limited exports 20 products worth $47.9M. Beyond Bromhexine, top products include Cetirizine, Metronidazole, Ciprofloxacin, Enalapril, Caffeine. View the complete J B Chemicals AND Pharmaceuticals Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Bromhexine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Bromhexine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: J B Chemicals AND Pharmaceuticals Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 53 individual customs records matching J B Chemicals AND Pharmaceuticals Limited exporting Bromhexine, covering 12 formulations to 3 countries via 9 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 109+ countries, 530+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Bromhexine Export Data from J B Chemicals AND Pharmaceuticals Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for J B Chemicals AND Pharmaceuticals Limited's Bromhexine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
J B Chemicals AND Pharmaceuticals Limited
Full Company Profile →
20 products · $47.9M total trade · 12 categories
Bromhexine Stats
Company Overview
Top Products by J B Chemicals AND Pharmaceuticals Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for J B Chemicals AND Pharmaceuticals Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Bromhexine. For current shipment-level data, contact TransData Nexus.